Reducing Antibiotic Prescribing in Family Practice
Launched by SEATTLE CHILDREN'S HOSPITAL · Sep 14, 2018
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to reduce the use of antibiotics in treating acute respiratory tract infections (ARTIs) in children and adults. These infections include common illnesses like ear infections, sore throats, sinus infections, bronchitis, and colds. In the U.S., many children with these infections are given antibiotics, even though most of these infections are caused by viruses, which don't respond to antibiotics. This overuse can lead to antibiotic resistance, making it harder to treat infections in the future.
To participate in this study, individuals must be seven months old or older and have a diagnosis of an ARTI, whether bacterial or viral. Unfortunately, younger infants (those under 6 months) are not eligible. Participants will help researchers understand better ways to manage these infections without relying so heavily on antibiotics. The trial is not yet recruiting, but it aims to gather important information that could improve treatment practices in family medicine.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children or adults with acute respiratory tract infections (ARTIs) defined as bacterial (acute otitis media \[AOM\], pharyngitis, and sinusitis) or viral (bronchitis and viral upper respiratory infection \[URI\]) based on their common etiologies.
- • 2. Seven months old and older
- Exclusion Criteria:
- • 1. 0 - 6 months old
About Seattle Children's Hospital
Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Rita Mangione-Smith, MD, MPH
Principal Investigator
Seattle Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials